Application of ZNF383 protein in preparing product for inhibiting activity of p53 protein

A protein, product technology, applied in the field of biomedicine

Active Publication Date: 2017-05-10
INST OF RADIATION MEDICINE ACAD OF MILITARY MEDICAL SCI OF THE PLA
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The p53 gene is so far found to be the most relevant gene to human tumors. Mutations of the p53 gene have been found in more tha

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of ZNF383 protein in preparing product for inhibiting activity of p53 protein
  • Application of ZNF383 protein in preparing product for inhibiting activity of p53 protein
  • Application of ZNF383 protein in preparing product for inhibiting activity of p53 protein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0096] Embodiment 1, the construction of plasmid and the preparation of oligomeric nucleic acid

[0097] 1. Construction of Myc-ZNF383 plasmid

[0098] The small fragment between the recognition sequences of the restriction endonucleases SalI and NotI of the pCMV-Myc plasmid was replaced with the DNA molecule shown in Sequence 2 in the sequence listing, and the resulting recombinant plasmid was the Myc-ZNF383 plasmid.

[0099] The Myc-ZNF383 plasmid expresses the ZNF383 protein shown in Sequence 1 in the Sequence Listing.

[0100] 2. Construction of Flag-p53 plasmid

[0101] The small fragment between the recognition sequences of the restriction endonucleases EcoRI and BamHI of the pCMV-Flag plasmid is replaced with the DNA molecule shown in sequence 4 in the sequence table, and the resulting recombinant plasmid is the Flag-p53 plasmid.

[0102] The Flag-p53 plasmid expresses the p53 protein shown in sequence 3 in the sequence listing.

[0103] 3. Preparation of oligonucleo...

Embodiment 2

[0110] Example 2, ZNF383 protein inhibits the activity of endogenous p53 protein in a dose-dependent manner

[0111] 1. Experiment 1

[0112] The experiment was repeated three times to take the average value, and the steps for each repetition were as follows:

[0113] 1. Cells (p53 + / + HCT116 cells or Hela cells) were seeded in 24-well plates containing 0.5 mL DMEM medium (8.0×10 per well 4 cells), and then placed at 37°C, 5% CO 2 Cultivate in an incubator, and when the fusion rate reaches 70-90%, they are randomly divided into four groups, and each group is set with three replicate wells, and the following treatments are carried out:

[0114] The first group: 20ng pG13L plasmid, 0.2ng pRL-TK plasmid and 0.4μg pCMV-Myc plasmid were added to each well for co-transfection;

[0115] The second group: add 0.1μg Myc-ZNF383 plasmid, 20ng pG13L plasmid, 0.2ng pRL-TK plasmid and 0.3μg pCMV-Myc plasmid to each well for co-transfection;

[0116] The third group: 0.2 μg Myc-ZNF383 p...

Embodiment 3

[0134] Example 3. ZNF383 protein depends on p53 protein to selectively down-regulate the expression of downstream apoptosis and immune-related target genes of p53 gene

[0135] 1. Experiment 1

[0136] The experiment was repeated three times to take the average value, and the steps for each repetition were as follows:

[0137] 1. Convert p53 + / + HCT116 cells were seeded in 6-well plates containing 2 mL of DMEM medium (2.0 × 10 per well 5cells), and then placed at 37°C, 5% CO 2 Culture in an incubator, and when the fusion rate reaches 70-90%, they are randomly divided into two groups, and each group is set with three replicate wells, and the following treatments are carried out:

[0138] Group 1: Add 2.0 μg pCMV-Myc plasmid to each well for co-transfection;

[0139] The second group: 2.0 μg Myc-ZNF383 plasmid was added to each well for co-transfection.

[0140] 2. 48 hours after step 1 was completed, the total RNA of each cell was extracted respectively, and then the first...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an application of ZNF383 protein in preparing a product for inhibiting the activity of p53 protein. An experiment proves that the ZNF383 protein can inhibit the activity of the p53 protein, can lower an expression quantity of apoptosis-associated target genes (such as puma genes or p53 AIPI genes), can lower the expression quantity of immune-associated target genes (such as IRF5 genes, ISG15 genes or IFN-beta genes), can lower an expression level of the puma protein, and can inhibit the binding of a p53 protein-associated signal pass and the p53 protein. Therefore, the ZNF383 protein has important application value in preparing the product for inhibiting the activity of the p53 protein.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to the application of ZNF383 protein in the preparation of products for inhibiting the activity of p53 protein. Background technique [0002] The KRAB zinc finger protein (KRAB-containing zinc finger protein, KZNF) family is the largest transcription factor / transcription regulator family in mammals, and its protein structure is mainly composed of the conserved KRAB (Krüppel -associated box) domain, the middle and the C-terminus contain multiple C2H2-type zinc finger structures that continuously recognize continuous DNA sequences. The KRAB domain recruits a variety of transcriptional repressors by binding to KAP-1 (KRAB-associated protein-1), forming a transcriptional repression complex, and the C-terminal zinc finger region binds to DNA and / or other transcription factors in the regulatory region of the target gene Finally, the transcriptional repression complex formed with KAP-1 is ancho...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/17A61K48/00A61P35/00C07K14/47C12N15/12C12N15/113
CPCA61K38/1758A61K48/0058C12N15/113C07K14/4703C12N2310/14
Inventor 田春艳王建贺福初张秀园原艳芝
Owner INST OF RADIATION MEDICINE ACAD OF MILITARY MEDICAL SCI OF THE PLA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap